View Full Paper

Owner Consent Verified
Dissertation 4.6

DEI Strategies for Pharmaceutical Firms: Data Quality And Bias | Evidence from South Asia

38
Pages
APA
Style
~ 40–55 mins
Reading Time
Governance FinTech Climate
Abstract

This dissertation investigates “DEI Strategies for Pharmaceutical Firms: Data Quality And Bias | Evidence from South Asia” using a panel regression with fixed effects. Through a institutional lens, the analysis integrates multi-source data to derive a stakeholder-aligned blueprint for researchers and practitioners.

Download PDF Order Similar Paper Save

DEI Strategies for Pharmaceutical Firms: Data Quality And Bias | Evidence from South Asia

ABSTRACT
DEI Strategies for Pharmaceutical Firms: Data Quality And Bias | Evidence from South Asia is unpacked across themes: ethics, scalability, benefits, and equity. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
22 Pages 4.4
Resilience And Continuity in AIOps for Urban Households: Evidence from Southeast Asia
Governance Health Food Systems
View Paper
20 Pages 4.6
InsurTech for Microfinance Institutions: Resilience And Continuity | 2023–2029 Trends
MLOps AIOps CV
View Paper
28 Pages 4.6
Customer Experience in Pharmacovigilance for NGOs in Global Health: 2022–2027 Trends
Supply Chain Tourism Risk
View Paper